Immune Pharmaceuticals Receives $2 Million Investment in Common...

2016-09-08T12:10:22-07:00

NEW YORK, Sept. 7, 2016 /PRNewswire/ — Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (“Immune”), a biopharmaceutical company focused on the development of targeted therapeutics for the treatment of inflammatory diseases and ...